Literature DB >> 26916137

The prognostic impact of para-aortic lymph node metastasis in pancreatic cancer: A systematic review and meta-analysis.

S Paiella1, M Sandini2, L Gianotti2, G Butturini3, R Salvia3, C Bassi3.   

Abstract

PURPOSE: To evaluate by a meta-analytic approach the long-term prognostic impact of para-aortic lymph node (PALN) involvement in resected ductal adenocarcinoma of the pancreas.
METHODS: MEDLINE, Embase, PubMed and the Cochrane Library were searched from January 1990 to June 2015. Trials reporting Kaplan-Meier curves and comparing overall long-term survival of negative and metastatic PALN in patients who underwent resection for pancreatic cancer were included. Lymph nodes were classified according to the Japan Pancreatic Society rules and identified using hematoxylin and eosin staining. Hazard ratios (HRs) and 95%CI were estimated for each trial and pooled in a meta-analysis.
RESULTS: Thirteen eligible studies including 2141 patients (364 positive PALN; 1777 negative PALN) were identified. Most of the studies were retrospective. Heterogeneity among trials was high (I(2) = 98.7%; p < .001). PALN metastasis was associated with increased mortality when compared with patients with negative PALN regardless regional nodal status [HR 1.85, 95%CI 1.48-2.31; p < .001]. Median survival was significantly decreased in patients with positive PALN (WMD = -4.92 months 95%CI -6.40; -3.43; p < .001). Moreover, metastatic PALN affected mortality also when regional lymph nodes were positive [HR 1.67, 95%CI 1.34-2.08; p < .001]. No publication bias was detected.
CONCLUSIONS: PALN metastasis appears to correlate with poor prognosis in patients with pancreatic adenocarcinoma. The assessment of PALN status may be considered for a more accurate staging of the disease and appropriated subgroup survival reporting. However, the definitive avoidance of the resection in case of intraoperative metastatic PALN needs further investigation.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Extended lymphadenectomy; Metastatic lymph node; Pancreatic adenocarcinoma; Para-aortic lymph node; Station 16 lymph node

Mesh:

Year:  2016        PMID: 26916137     DOI: 10.1016/j.ejso.2016.02.003

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  19 in total

Review 1.  Oligometastatic Disease in Pancreatic Cancer - How to Proceed?

Authors:  Bernhard W Renz; Stefan Boeck; Falk Roeder; Christoph Trumm; Volker Heinemann; Jens Werner
Journal:  Visc Med       Date:  2017-02-10

2.  Para-aortic lymph node metastases in pancreatic cancer should not be considered a watershed for curative resection.

Authors:  Sebastian Hempel; Verena Plodeck; Franz Mierke; Marius Distler; Daniela E Aust; Hans-Detlev Saeger; Jürgen Weitz; Thilo Welsch
Journal:  Sci Rep       Date:  2017-08-09       Impact factor: 4.379

3.  Para-aortic lymph node involvement should not be a contraindication to resection of pancreatic ductal adenocarcinoma.

Authors:  Rupaly Pande; Shafiq Chughtai; Manish Ahuja; Rachel Brown; David C Bartlett; Bobby V Dasari; Ravi Marudanayagam; Darius Mirza; Keith Roberts; John Isaac; Robert P Sutcliffe; Nikolaos A Chatzizacharias
Journal:  World J Gastrointest Surg       Date:  2022-05-27

4.  Underutilization of Surgery in Periampullary Cancer Treatment.

Authors:  Christoph W Michalski; Bing Liu; Max Heckler; Susanne Roth; Huihui Sun; Ulrike Heger; Markus W Büchler; Thilo Hackert
Journal:  J Gastrointest Surg       Date:  2018-08-07       Impact factor: 3.452

5.  Survival in resectable pancreatic ductal adenocarcinoma with para-aortic lymph node dissection: A retrospective study in Vietnamese population.

Authors:  Lan Thi Nguyen; Hung Van Nguyen; Dang Hai Do; Khiem Thanh Nguyen; Anh Tuan Do; Ha Hoang Pham; Chinh Duc Nguyen
Journal:  Ann Med Surg (Lond)       Date:  2021-05-01

6.  Pancreaticoduodenectomy: Secondary stenting of the celiac trunk after inefficient median arcuate ligament release and reoperation as an alternative to simultaneous hepatic artery reconstruction.

Authors:  Théophile Guilbaud; Jacques Ewald; Olivier Turrini; Jean Robert Delpero
Journal:  World J Gastroenterol       Date:  2017-02-07       Impact factor: 5.742

Review 7.  A Contemporary Review of the Treatment Landscape and the Role of Predictive and Prognostic Biomarkers in Pancreatic Adenocarcinoma.

Authors:  Irene S Yu; Winson Y Cheung
Journal:  Can J Gastroenterol Hepatol       Date:  2018-02-12

8.  Para-aortic node involvement is not an independent predictor of survival after resection for pancreatic cancer.

Authors:  Cosimo Sperti; Mario Gruppo; Stella Blandamura; Michele Valmasoni; Gioia Pozza; Nicola Passuello; Valentina Beltrame; Lucia Moletta
Journal:  World J Gastroenterol       Date:  2017-06-28       Impact factor: 5.742

9.  Analysis of prognostic factors for pancreatic head cancer according to para-aortic lymph node.

Authors:  Jian-Yu Lin; Xing-Mao Zhang; Jian-Tiao Kou; Hua Fa; Xin-Xue Zhang; Yang Dai; Qiang He
Journal:  Cancer Med       Date:  2016-08-19       Impact factor: 4.452

10.  Prognostic value of number of negative lymph node in patients with stage II and IIIa non-small cell lung cancer.

Authors:  Shengguang Wang; Bin Zhang; Chenguang Li; Chao Cui; Dongsheng Yue; Bowen Shi; Qiang Zhang; Zhenfa Zhang; Xi Zhang; Changli Wang
Journal:  Oncotarget       Date:  2017-05-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.